Spruce Biosciences, Inc. Common Stock Cash Flow Reinvestment Rate

Latest as of June 2023: 11.04x

Spruce Biosciences, Inc. Common Stock cash flow reinvestment rate. Spruce Biosciences, Inc. Common Stock (SPRB) has a Cash Flow Reinvestment Rate of 11.04x as of June 2023, reinvesting $22.00 Million (capex $0.00 plus investments $22.00 Million) from operating cash flow of $1.99 Million. Explore cash flow to debt ratio of Spruce Biosciences, Inc. Common Stock to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

11.04x
(Capex + Investments) / Operating CF

Total Reinvested

$22.00 Million
Capex + Investments

Operating Cash Flow

$1.99 Million
USD

Capital Expenditures

$0.00
USD

Spruce Biosciences, Inc. Common Stock Cash Flow Reinvestment Rate by Year (None–None)

Spruce Biosciences, Inc. Common Stock cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Spruce Biosciences, Inc. Common Stock. For the full cash flow conversion analysis, see SPRB cash generation efficiency.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow